» Articles » PMID: 10826987

Ion Channels and Epilepsy in Man and Mouse

Overview
Publisher Elsevier
Specialties Biology
Genetics
Date 2000 May 29
PMID 10826987
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Inherited disorders of voltage-gated ion channels are a recently recognized etiology of epilepsy in the developing and mature central nervous system. Two human epilepsy syndromes, benign familial neonatal convulsions and generalized epilepsy with febrile seizures plus, represent K+ and Na+ channelopathies, and other newly defined syndromes have now been mapped to chromosomal regions that are rich in ion channel genes. Experimental mouse models promise a resolution of their intriguing pathophysiology, which includes a diverse array of cellular phenotypes consistent with the differential contributions of individual channels to excitability in neural networks.

Citing Articles

mTOR-dependent alterations of Kv1.1 subunit expression in the neuronal subset-specific Pten knockout mouse model of cortical dysplasia with epilepsy.

Nguyen L, Anderson A Sci Rep. 2018; 8(1):3568.

PMID: 29476105 PMC: 5824782. DOI: 10.1038/s41598-018-21656-8.


Retigabine, a Kv7.2/Kv7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 Mutations.

Ihara Y, Tomonoh Y, Deshimaru M, Zhang B, Uchida T, Ishii A PLoS One. 2016; 11(2):e0150095.

PMID: 26910900 PMC: 4766199. DOI: 10.1371/journal.pone.0150095.


Disruption of polycystin-L causes hippocampal and thalamocortical hyperexcitability.

Yao G, Luo C, Harvey M, Wu M, Schreiber T, Du Y Hum Mol Genet. 2015; 25(3):448-58.

PMID: 26612203 PMC: 4731019. DOI: 10.1093/hmg/ddv484.


Computer aided identification of sodium channel blockers in the clinical treatment of epilepsy using molecular docking tools.

Shaheen U, Akka J, Hinore J, Girdhar A, Bandaru S, Sumithnath T Bioinformation. 2015; 11(3):131-7.

PMID: 25914447 PMC: 4403034. DOI: 10.6026/97320630011131.


HCN and KV7 (M-) channels as targets for epilepsy treatment.

Shah M, Huang Z, Martinello K Neuropharmacology. 2012; 69:75-81.

PMID: 22446478 PMC: 4104618. DOI: 10.1016/j.neuropharm.2012.03.005.